Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMA is a French software company that develops the XpertEye assisted-reality and remote collaboration platform for frontline workers. Its products are used across industrial and medical settings for remote assistance, inspection, workflow management, training, documentation, and related productivity use cases. In healthcare, the company positions XpertEye for medical institutions and eHealth workflows rather than as a drug-development company. AMA appears to be commercially active, publicly listed, and operating internationally with offices across Europe, Asia-Pacific, and the United States. The business is best characterized as a digital workflow and assisted-reality software provider with some healthcare exposure, not a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMA XpertEye.